Cytokinetics succeeds where Bristol Myers failed in heart muscle disease

May 5, 2026 07:30 AM EDT R&DPharma Cy­to­ki­net­ics suc­ceeds where Bris­tol My­ers failed in heart mus­cle dis­ease Elizabeth Cairns Senior biopharma journalist Cy­to­ki­net­ics’ pill for a heart mus­cle dis­or­der called hy­per­trophic car­diomy­opa­thy could see its ad­dress­able mar­ket dou­ble af­ter it suc­ceed­ed in a piv­otal tri­al for an­oth­er … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER